oxidopamine has been researched along with Dementia in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fan, Y | 1 |
Li, M | 1 |
Wu, C | 1 |
Wu, Y | 1 |
Han, J | 1 |
Wu, P | 1 |
Huang, Z | 1 |
Wang, Q | 1 |
Zhao, L | 1 |
Chen, D | 1 |
Zhu, M | 1 |
Lindner, MD | 1 |
Cain, CK | 1 |
Plone, MA | 1 |
Frydel, BR | 1 |
Blaney, TJ | 1 |
Emerich, DF | 1 |
Hoane, MR | 1 |
2 other studies available for oxidopamine and Dementia
Article | Year |
---|---|
Chronic Cerebral Hypoperfusion Aggravates Parkinson's Disease Dementia-Like Symptoms and Pathology in 6-OHDA-Lesioned Rat through Interfering with Sphingolipid Metabolism.
Topics: Alzheimer Disease; Animals; Brain Ischemia; Dementia; Disease Models, Animal; Lipid Metabolism; Male | 2022 |
Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Brain Mapping; Corpus Striatum; Dementia; Dopa | 1999 |